Erste Asset Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,800
| Closed | -$36.8K | – | 880 |
|
|
2024
Q3 | $36.8K | Hold |
9,800
| – | – | ﹤0.01% | 516 |
|
|
2024
Q2 | $41.2K | Hold |
9,800
| – | – | ﹤0.01% | 512 |
|
|
2024
Q1 | $149K | Hold |
9,800
| – | – | ﹤0.01% | 481 |
|
|
2023
Q4 | $153K | Hold |
9,800
| – | – | ﹤0.01% | 493 |
|
|
2023
Q3 | $192K | Hold |
9,800
| – | – | ﹤0.01% | 479 |
|
|
2023
Q2 | $276K | Hold |
9,800
| – | – | ﹤0.01% | 466 |
|
|
2023
Q1 | $163K | Hold |
9,800
| – | – | ﹤0.01% | 504 |
|
|
2022
Q4 | $180K | Hold |
9,800
| – | – | ﹤0.01% | 497 |
|
|
2022
Q3 | $211K | Hold |
9,800
| – | – | ﹤0.01% | 493 |
|
|
2022
Q2 | $266K | Hold |
9,800
| – | – | 0.01% | 488 |
|
|
2022
Q1 | $447K | Hold |
9,800
| – | – | 0.01% | 446 |
|
|
2021
Q4 | $818K | Hold |
9,800
| – | – | 0.01% | 379 |
|
|
2021
Q3 | $603K | Hold |
9,800
| – | – | 0.01% | 384 |
|
|
2021
Q2 | $521K | Hold |
9,800
| – | – | 0.01% | 406 |
|
|
2021
Q1 | $395K | Hold |
9,800
| – | – | 0.01% | 404 |
|
|
2020
Q4 | $534K | Buy |
+9,800
| New | +$534K | 0.01% | 380 |
|